7.01 USD
↘ 0.33 (4.50%)LIVE (AS OF 02:24 PM EST)
PUMA BIOTECHNOLOGY INC (PBYI) trades at $7.01 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone and a bullish Golden Cross on the moving averages. Valuation metrics suggest PBYI is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.